November 25, 2014
Merck Serono said on November 20 that it has entered into an agreement with Fujifilm Pharma to transfer the marketing rights in Japan for Merck Serono’s Saizen (recombinant somatropin) for the treatment of short stature associated with growth hormone deficiency,...read more